ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,161, issued on Sept. 9, was assigned to Fudan University (Shanghai).
"Compound for treating neurodegenerative disorders" was invented by Boxun Lu (Shanghai), Yiyan Fei (Shanghai), Yu Ding (Shanghai) and Yongjun Dang (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to use of a compound with a substituted bicyclic structure, a pharmaceutically acceptable salt, stereoisomer, solvate, polymorph, tautomer, isotopic compound, metabolite or prodrug thereof in the preparation of a medicament for preventing or treating polyglutamine (polyQ) related disorders."
The patent was filed on March 11, 2020, under Application N...